missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Recombinant Proteins
  4. Novus Biologicals™ Recombinant Human AKR1B1 Protein

Novus Biologicals™ Recombinant Human AKR1B1 Protein

Product Code. 18567701 Shop All Bio Techne Products
Click to view available options
Quantity:
0.5 mg
Unit Size:
0.5mg
This item is not returnable. View return policy

Product Code. 18567701

Brand: Novus Biologicals™ NBC1229250.5mg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Highly purified and high bioactivity. Generating reliable and reproducible results.

An un-tagged recombinant protein corresponding to the amino acids 1-316 of Human AKR1B1 The Recombinant Human AKR1B1 Protein is derived from E. coli. The Recombinant Human AKR1B1 Protein has been validated for the following applications: Functional, SDS-Page, Bioactivity.
TRUSTED_SUSTAINABILITY

Specifications

Accession Number P15121
For Use With (Application) Bioactivity
Formulation 20mM Tris-HCl buffer (pH 8.0), 1mM DTT, 10% glycerol
Gene ID (Entrez) 231
Molecular Weight (g/mol) 35.8kDa
Name AKR1B1 Protein
Purification Method Protein
Quantity 0.5 mg
Source E. Coli
Immunogen Aldose reductase, 1-316aa, Human, Recombinant, E.coli (NP_001619)
Storage Requirements -80°C. Avoid freeze-thaw cycles.
Regulatory Status RUO
Conjugate Unconjugated
Species Human
Recombinant Recombinant
Purity or Quality Grade >95%, by SDS-PAGE
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.